Search results
8 gru 2023 · Health experts provide clear answers to common questions about the newest GLP-1 weight loss medication. The Mounjaro-like anti-obesity prescription drug Zepbound is now available at...
9 lis 2023 · The specific amount of weight you might lose from Zepbound is uncertain, but significant weight loss ranging from 35.5 lb (16.1 kg) to 52.0 lb (23.6 kg) was observed in the 72-week SURMOUNT-1 clinical trial, which compared different Zepbound (tirzepatide) doses to a placebo (inactive treatment).
10 lis 2023 · Compared with rival injectables Wegovy and Ozempic (semaglutide), Zepbound leads to greater weight loss. Here’s more on price, availability, and side effects.
9 lis 2023 · In SURMOUNT-2, participants taking Zepbound 15 mg achieved weight reductions of 16%, losing an average of 34 pounds. Nearly half of all SURMOUNT-2 participants on Zepbound were able to lower their A1C to what is considered a normal level, 5.7%.
Zepbound is not for cosmetic weight loss. For adults with obesity (BMI of ≥30 kg/m2) or with overweight (BMI of ≥27 kg/m2) with at least 1 weight-related comorbidity as an adjunct to a reduced-calorie diet and increased physical activity1.
Zepbound® (tirzepatide) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. Learn more about Zepbound.
31 maj 2024 · Zepbound is a new medication used for weight loss and maintenance in people who are overweight or obese. It was approved by the U.S. Food and Drug Administration (FDA) in 2023. It can be difficult to determine how much Zepbound is appropriate for you and how to dose this medication.
